EQS-Adhoc: STRATEC POSTS IMPAIRMENTS, REPORTS PRELIMINARY RESULTS FOR 2025, AND OFFERS GUIDANCE FOR 2026
|
EQS-Ad-hoc: STRATEC SE / Key word(s): Significant extraordinary expenses/Forecast / Other STRATEC POSTS IMPAIRMENTS, REPORTS PRELIMINARY RESULTS FOR 2025, AND OFFERS GUIDANCE FOR 2026 Birkenfeld, March 25, 2026 Based on preliminary figures, STRATEC SE, Birkenfeld, Germany (Frankfurt: SBS; Prime Standard) can report an EBIT margin of 10.0% for the 2025 financial year (previous year: 13.0%) after adjustment for one-off items, including the impairments presented below. Consolidated sales for 2025 are expected to amount to € 250.9 million (previous year: € 257.6 million), falling 1.1% short of the previous year’s figure on a constant-currency basis (nominal: -2.6%). The company therefore met its most recently communicated financial guidance (constant-currency sales at around the previous year’s level; adjusted EBIT margin at lower end of corridor of 10.0% to 12.0%). In connection with the annual impairment test performed when preparing the consolidated financial statements as of December 31, 2025, STRATEC is recognizing impairments totaling € 10.5 million on intangible assets and inventories. These impairments for the 2025 financial year essentially relate to a delayed market launch and to decreased sales potential for a product family in the Diatron brand. Given robust demand for systems in the fields of immunoassays and immunohematology and a slight recovery in the field of molecular diagnostics, for the 2026 financial year STRATEC expects to generate year-on-year constant-currency consolidated sales growth in a medium to high single-digit percentage range. The resultant benefits of scale are expected to be partly to fully offset by rising input costs attributable to factors including the impact of geopolitical conflicts. Accordingly, the adjusted EBIT margin for 2026 is expected at around the previous year’s level. Based on intra-year order forecasts, sales growth will predominantly materialize in the second half of 2026, while the first quarter is expected to see a sharp reduction in sales, accompanied by an associated dip in profitability, not least as a result of the high volume of development sales realized in the previous year. STRATEC will publish its definitive results for the 2025 financial year and its 2025 Annual Report on schedule on April 28, 2026. Due in particular to numerous upcoming product launches, STRATEC will on the same date also publish new targets for the development in its sales and margin in the medium term. FURTHER INFORMATION IS AVAILABLE FROM: End of Inside Information
25-March-2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | STRATEC SE |
| Gewerbestr. 37 | |
| 75217 Birkenfeld | |
| Germany | |
| Phone: | +49 (0)7082 7916 0 |
| Fax: | +49 (0)7082 7916 999 |
| E-mail: | info@stratec.com |
| Internet: | www.stratec.com |
| ISIN: | DE000STRA555 |
| WKN: | STRA55 |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate BSX |
| EQS News ID: | 2297992 |
| End of Announcement | EQS News Service |
|
|
2297992 25-March-2026 CET/CEST
Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.
| The most important financial data at a glance | ||||||||
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | ||
| Sales1 | 250,10 | 287,34 | 274,63 | 261,91 | 257,62 | 250,86 | 268,00 | |
| EBITDA1,2 | 56,27 | 66,43 | 58,07 | 40,08 | 46,98 | 33,81 | 38,00 | |
| EBITDA-Margin3 | 22,50 | 23,12 | 21,15 | 15,30 | 18,24 | 13,48 | 14,18 | |
| EBIT1,4 | 33,68 | 48,18 | 41,14 | 22,39 | 27,54 | 9,07 | 20,00 | |
| EBIT-Margin5 | 13,47 | 16,77 | 14,98 | 8,55 | 10,69 | 3,62 | 7,46 | |
| Net Profit (Loss)1 | 25,18 | 39,96 | 29,22 | 13,07 | 16,02 | -0,24 | 11,50 | |
| Net-Margin6 | 10,07 | 13,91 | 10,64 | 4,99 | 6,22 | -0,10 | 4,29 | |
| Cashflow1,7 | 31,85 | 63,47 | 10,28 | 19,43 | 48,71 | -0,43 | 26,00 | |
| Earnings per share8 | 2,07 | 3,28 | 2,41 | 1,07 | 1,32 | -0,02 | 0,87 | |
| Dividend per share8 | 0,90 | 0,95 | 0,97 | 0,55 | 0,60 | 0,60 | 0,60 | |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: PricewaterhouseCoopers
All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.
| INVESTOR-INFORMATION | ||||||
| ©boersengefluester.de | ||||||
| Stratec | ||||||
| WKN | ISIN | Legal Type | Marketcap | IPO | Recommendation | Plus Code |
| STRA55 | DE000STRA555 | SE | 213,98 Mio € | 25.08.1998 | Halten | 8FWCVH7J+C5 |
| PE 2027e | PE 10Y-Ø | BGFL-Ratio | Shiller-PE | PB | PCF | KUV |
| 12,14 | 31,71 | 0,38 | 11,60 | 0,93 | -494,18 | 0,85 |
|
Dividend '2023 in € |
Dividend '2024 in € |
Dividend '2025e in € |
Div.-Yield '2025e in % |
| 0,55 | 0,60 | 0,60 | 3,41% |
| Annual General Meeting | Q1-figures | Q2-figures | Q3-figures | Annual press conference |
| 23.06.2026 | 11.05.2026 | 14.08.2026 | 05.11.2026 | 28.04.2026 |
| Distance 60-days-line | Distance 200-days-line | Performance YtD | Performance 52 weeks | IPO |
| -8,15% | -24,82% | -21,60% | -28,02% | +496,61% |
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
